Description
CONSOLIDATED TAMSULOSIN
First action · last action
2015-04-02 · 2015-04-02
Transactions
1
First transaction's obligation
$1,720,440
Base + all options value (sum of deltas)
$1,720,440
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
8
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2015-04-02+$1,720,440= $1,720,440
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2015-04-02 | +$1,720,440 | $1,720,440 | CONSOLIDATED TAMSULOSIN |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI GQLDJJ8AQNN5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36E79726D0041 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36E79726D0042 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36E79726D0022 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36E79726D0014 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36E79726D0023 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36E79726D0018 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under 6505 from NATIONAL CMOP OFFICE (NCO) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA77016P0844 | ROCHE DIABETES CARE INC | NATIONAL CMOP OFFICE (NCO) | $494,384 | FY2016 |
| VA77016P0843 | D & H WHOLESALE MEDICAL, INC. | NATIONAL CMOP OFFICE (NCO) | $30,360 | FY2016 |
| VA77016P0828 | WESTMINSTER PHARMACEUTICALS, LLC | NATIONAL CMOP OFFICE (NCO) | $24,615 | FY2016 |
| VA77016E0865 | SOUND PACKAGING LLC | NATIONAL CMOP OFFICE (NCO) | $11,462 | FY2016 |
| VA77016E0862 | 3M COMPANY | NATIONAL CMOP OFFICE (NCO) | $9,177 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA77015P0267_3600_-NONE-_-NONE- · retrieved 2026-09-26.